Join us in Las Vegas for this Midday Symposium Conducted at the 2022 ASHP Midyear Clinical Meeting & Exhibition!

Existing and Emerging Clostridioides difficile Infection Therapies: Importance of Microbiome Restoration

Clostridioides difficile infection (CDI) is a threat to public health and recurrence is common. This educational activity will review the burden of CDI on the health system and the logistical complexities of existing and emerging therapeutics. Current guideline recommendations for the treatment of primary and recurrent CDI will be reviewed. The activity will conclude with a discussion of existing and emerging strategies for the treatment of patients with recurrent CDI, including the role of microbiome restoration.

Tuesday, Dec. 6

11:30 a.m. - 1 p.m. PT

Come early! Seating is limited and provided on a first-come, first-served basis.

Symposium Location: Islander Ballroom H, Lower Level

Mandalay Bay North Convention Center

Can't make it to Vegas? Tune into the Live Webinar Broadcast: 

Tuesday, Dec. 6

11:30 a.m. - 1 p.m. PT (2:30 - 4 p.m. ET)

Registration is required for the webinar. 

Featuring...

Travis J. Carlson

PharmD, BCIDP
Activity Chair

Assistant Professor
High Point University
High Point, North Carolina

Kelly R. Reveles

PharmD, PhD, BCPS

Associate Professor, College of Pharmacy
The University of Texas at Austin
San Antonio, Texas

Target Audience

The target audience for this educational activity is pharmacists who practice in hospitals, health systems, and ambulatory clinics as well as transitions of care pharmacists who care for or are interested in the care of patients with recurrent CDI.

Learning Objectives

• Compare recently released guideline recommendations for the treatment of CDI in adults.
• Evaluate existing and emerging therapeutic strategies for the treatment of recurrent CDI.
• Explain the implementation challenges of microbiome restoration strategies in patients with recurrent CDI.

Agenda

11:30 a.m. - Welcome and Introductions
Travis Carlson, PharmD, BCIDP
Kelly Reveles, PharmD, PhD, BCPS

11:35 a.m. - Review of CDI Epidemiology and Guideline Recommendations
Travis Carlson, PharmD, BCIDP

11:50 a.m. - Safety and Efficacy of Emerging Therapies for Recurrent CDI: The Importance of Microbiome Restoration
Kelly Reveles, PharmD, PhD, BCPS

12:10 p.m. - Transitions of Care and Operational Considerations of Emerging Therapies for Recurrent CDI
Travis Carlson, PharmD, BCIDP

12:40 p.m. - Faculty Discussion and Questions and Answers
Travis Carlson, PharmD, BCIDP
Kelly Reveles, PharmD, PhD, BCPS

Accredited for CPE

ACPE #: 0204-0000-22-424-L01-P

CE Credit: 1.5 contact hours (0.15 CEUs)

Activity Type: Application-based

Activity Fee: No charge 

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Provided by ASHP.
Supported by an educational grant from Ferring Pharmaceuticals Inc.
For questions and assistance to participate, contact us.